MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617083967 A) filed by Johnson & Johnson Enterprise Innovation Inc. on July 08, 2026, for Pharmaceutical Compositions Of An A2a Receptor Antagonist.
Inventors include Zhu, Donghua; and Ji, Chongmin.
The application for the patent was published on September 04, 2026, under issue no. 36/2026.
Abstract: Disclosed is pharmaceutical compositions of an A2a receptor, and the dosage form thereof with good stability and dissolution performance, as well as preparation methods thereof and uses thereof.
Disclaimer: Curated by HT Syndication.
